These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7898771)

  • 21. Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens.
    Fuentealba JA; Gysling K; Magendzo K; Andrés ME
    J Neurosci Res; 2006 Aug; 84(2):450-9. PubMed ID: 16676328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity.
    Collins SL; Gerdes RM; D'Addario C; Izenwasser S
    Behav Pharmacol; 2001 Jul; 12(4):237-45. PubMed ID: 11548109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
    Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
    Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kappa-opioid receptor modulation of nicotine-induced behaviour.
    Hahn B; Stolerman IP; Shoaib M
    Neuropharmacology; 2000 Oct; 39(13):2848-55. PubMed ID: 11044755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens.
    Chefer VI; Shippenberg TS
    Eur J Neurosci; 2006 Jan; 23(1):229-38. PubMed ID: 16420432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kappa opioid effects on fetal behavior: central administration of U50,488.
    Petrov ES; Varlinskaya EI; Robinson SR; Smotherman WP; de Costa BR; Rice KC
    Physiol Behav; 1994 Jul; 56(1):175-82. PubMed ID: 8084898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
    Yu XC; Wang HX; Pei JM; Wong TM
    J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Delayed electrical uncoupling is involved in kappa-opioid receptor activation -induced cardioprotective effect in the isolated rat heart].
    Chen BP; Fan FY; Mao HJ; Xia Q
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Feb; 22(1):64-70. PubMed ID: 21186583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dopamine and kappa opioid receptors on fetal responsiveness to perioral stimuli.
    Robinson SR; Moody CA; Spear LP; Smotherman WP
    Dev Psychobiol; 1993 Jan; 26(1):37-50. PubMed ID: 8382637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological stimuli decreasing nucleus accumbens dopamine can act as positive reinforcers but have a low addictive potential.
    Marinelli M; Barrot M; Simon H; Oberlander C; Dekeyne A; Le Moal M; Piazza PV
    Eur J Neurosci; 1998 Oct; 10(10):3269-75. PubMed ID: 9786220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the kappa-opioid agonist U50,488 on parturition in rats.
    Douglas AJ; Clarke G; MacMillan SJ; Bull PM; Neumann I; Way SA; Wright DM; McGrory BG; Russell JA
    Br J Pharmacol; 1993 May; 109(1):251-8. PubMed ID: 8388299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B).
    Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM
    Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of kappa-opioid receptor mechanisms in the calcitonin-induced potentiation of opioid effects at the hypothalamus-pituitary-adrenocortical axis.
    Milanés MV; Vargas ML; Martín MI
    Eur J Pharmacol; 1994 Dec; 271(1):103-9. PubMed ID: 7698193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered neurochemical and behavioral development of 10-day-old rats perinatally exposed to the kappa opioid agonist U-50,488H.
    Shieh GJ; Walters DE
    Neurosci Lett; 1994 Jul; 176(1):37-40. PubMed ID: 7970232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms.
    Murakawa K; Hirose N; Takada K; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Eur J Pharmacol; 2004 Apr; 491(1):31-6. PubMed ID: 15102530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of kappa opioid agonists on the discriminative stimulus effects of cocaine in rhesus monkeys.
    Negus SS; Mello NK
    Exp Clin Psychopharmacol; 1999 Nov; 7(4):307-17. PubMed ID: 10609965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens.
    Schad CA; Justice JB; Holtzman SG
    J Neurochem; 1996 Dec; 67(6):2292-9. PubMed ID: 8931460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
    Takemori AE; Schwartz MM; Portoghese PS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonspecific effects of the selective kappa-opioid receptor agonist U-50,488H on dopamine uptake and release in PC12 cells.
    Chudapongse N; Kim SY; Kramer RE; Ho IK
    J Pharmacol Sci; 2003 Nov; 93(3):372-5. PubMed ID: 14646257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.